Compound and pharmaceutical compositions of Formula by blockade of the CB.sub.1 receptors via an inverse agonism mechanism, and are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment with antipsychotics and have increased bioavailability. ##STR00001##